Cargando…

Cardiovascular and Lung Involvement in Patients with Autoimmune Pancreatitis

Introduction: Immunoglobulin G4-related disease (IgG4-RD) is a systemic immune-mediated disease characterised pathologically by the infiltration of IgG4-bearing plasma cells into the involved organs. Autoimmune pancreatitis (AIP) is a form of chronic pancreatitis with a heavy lymphocytic infiltratio...

Descripción completa

Detalles Bibliográficos
Autores principales: Nikolic, Sara, Brehmer, Katharina, Panic, Nikola, Valente, Roberto, Löhr, J.-Matthias, Vujasinovic, Miroslav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074280/
https://www.ncbi.nlm.nih.gov/pubmed/32028650
http://dx.doi.org/10.3390/jcm9020409
_version_ 1783506797435289600
author Nikolic, Sara
Brehmer, Katharina
Panic, Nikola
Valente, Roberto
Löhr, J.-Matthias
Vujasinovic, Miroslav
author_facet Nikolic, Sara
Brehmer, Katharina
Panic, Nikola
Valente, Roberto
Löhr, J.-Matthias
Vujasinovic, Miroslav
author_sort Nikolic, Sara
collection PubMed
description Introduction: Immunoglobulin G4-related disease (IgG4-RD) is a systemic immune-mediated disease characterised pathologically by the infiltration of IgG4-bearing plasma cells into the involved organs. Autoimmune pancreatitis (AIP) is a form of chronic pancreatitis with a heavy lymphocytic infiltration and two distinct histopathological subtypes, namely: lymphoplasmacytic sclerosing pancreatitis (AIP type 1) and idiopathic duct-centric pancreatitis (AIP type 2). Lung involvement and aortic involvement have been reported in 12% and 9% of patients with systemic IgG4-RD, respectively. In series including patients with AIP, both lung and aortic involvement were described in 2% of the patients. Most of the epidemiological data come from Japan, and there is a lack of information from Europe, especially the Scandinavian countries. Patients and methods: We performed a single-centre retrospective study on a prospectively collected cohort of patients diagnosed with AIP at the Department for Digestive Diseases at Karolinska University Hospital in Stockholm, Sweden, from 2004 to 2019. Demographic and clinical data were collected from the medical charts. Results: One hundred and thirty-three patients with AIP were analysed. Six patients were excluded because they lacked some of the clinical data relevant to the study. Demographic and clinical features of 127 patients were presented. There were 98 patients with AIP type 1-35 (35.7%) female and 63 (64.3%) male, with a mean age of 55.4 ± 18.2. Among them, 15 (15.3%) patients had lung and/or cardiovascular involvement-11 (11.2%) patients had lung involvement, 10 (10.2%) patients had cardiovascular involvement (six patients had both). Most of them (67.0%) had never smoked. The mean follow-up time of the patients with AIP type 1 was 49 months. Conclusions: Lung and/or cardiovascular involvement were diagnosed in 15 (15.3%) patients in our historical cohort of patients with AIP type 1. Most of the lung involvement was presented in the form of nodular lesions in the lungs, non-specific infiltrates, “ground-glass” appearance with pleura thickening, and effusion. Aortic involvement was a major form of vascular involvement in patients with AIP, as in previous published studies on patients with IgG4-RD.
format Online
Article
Text
id pubmed-7074280
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70742802020-03-19 Cardiovascular and Lung Involvement in Patients with Autoimmune Pancreatitis Nikolic, Sara Brehmer, Katharina Panic, Nikola Valente, Roberto Löhr, J.-Matthias Vujasinovic, Miroslav J Clin Med Article Introduction: Immunoglobulin G4-related disease (IgG4-RD) is a systemic immune-mediated disease characterised pathologically by the infiltration of IgG4-bearing plasma cells into the involved organs. Autoimmune pancreatitis (AIP) is a form of chronic pancreatitis with a heavy lymphocytic infiltration and two distinct histopathological subtypes, namely: lymphoplasmacytic sclerosing pancreatitis (AIP type 1) and idiopathic duct-centric pancreatitis (AIP type 2). Lung involvement and aortic involvement have been reported in 12% and 9% of patients with systemic IgG4-RD, respectively. In series including patients with AIP, both lung and aortic involvement were described in 2% of the patients. Most of the epidemiological data come from Japan, and there is a lack of information from Europe, especially the Scandinavian countries. Patients and methods: We performed a single-centre retrospective study on a prospectively collected cohort of patients diagnosed with AIP at the Department for Digestive Diseases at Karolinska University Hospital in Stockholm, Sweden, from 2004 to 2019. Demographic and clinical data were collected from the medical charts. Results: One hundred and thirty-three patients with AIP were analysed. Six patients were excluded because they lacked some of the clinical data relevant to the study. Demographic and clinical features of 127 patients were presented. There were 98 patients with AIP type 1-35 (35.7%) female and 63 (64.3%) male, with a mean age of 55.4 ± 18.2. Among them, 15 (15.3%) patients had lung and/or cardiovascular involvement-11 (11.2%) patients had lung involvement, 10 (10.2%) patients had cardiovascular involvement (six patients had both). Most of them (67.0%) had never smoked. The mean follow-up time of the patients with AIP type 1 was 49 months. Conclusions: Lung and/or cardiovascular involvement were diagnosed in 15 (15.3%) patients in our historical cohort of patients with AIP type 1. Most of the lung involvement was presented in the form of nodular lesions in the lungs, non-specific infiltrates, “ground-glass” appearance with pleura thickening, and effusion. Aortic involvement was a major form of vascular involvement in patients with AIP, as in previous published studies on patients with IgG4-RD. MDPI 2020-02-03 /pmc/articles/PMC7074280/ /pubmed/32028650 http://dx.doi.org/10.3390/jcm9020409 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nikolic, Sara
Brehmer, Katharina
Panic, Nikola
Valente, Roberto
Löhr, J.-Matthias
Vujasinovic, Miroslav
Cardiovascular and Lung Involvement in Patients with Autoimmune Pancreatitis
title Cardiovascular and Lung Involvement in Patients with Autoimmune Pancreatitis
title_full Cardiovascular and Lung Involvement in Patients with Autoimmune Pancreatitis
title_fullStr Cardiovascular and Lung Involvement in Patients with Autoimmune Pancreatitis
title_full_unstemmed Cardiovascular and Lung Involvement in Patients with Autoimmune Pancreatitis
title_short Cardiovascular and Lung Involvement in Patients with Autoimmune Pancreatitis
title_sort cardiovascular and lung involvement in patients with autoimmune pancreatitis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074280/
https://www.ncbi.nlm.nih.gov/pubmed/32028650
http://dx.doi.org/10.3390/jcm9020409
work_keys_str_mv AT nikolicsara cardiovascularandlunginvolvementinpatientswithautoimmunepancreatitis
AT brehmerkatharina cardiovascularandlunginvolvementinpatientswithautoimmunepancreatitis
AT panicnikola cardiovascularandlunginvolvementinpatientswithautoimmunepancreatitis
AT valenteroberto cardiovascularandlunginvolvementinpatientswithautoimmunepancreatitis
AT lohrjmatthias cardiovascularandlunginvolvementinpatientswithautoimmunepancreatitis
AT vujasinovicmiroslav cardiovascularandlunginvolvementinpatientswithautoimmunepancreatitis